ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1606

Association of African- American Ethnicity and Smoking Status and Total and Individual Damage Index in Systemic Lupus Erythematosus

Romy Kallas1, Jessica Li 1 and Michelle Petri 1, 1Johns Hopkins University School of Medicine, Baltimore, MD

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: modifiable risk and African-Americans, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: SLE – Clinical Poster II: Comorbidities

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Smoking and African- American ethnicity are risk factors for systemic lupus erythematosus (SLE). Smoking has been associated with increased prevalence of SLE, increased disease activity and decreased effectiveness of hydroxychloroquine in cutaneous lupus. The objective of the study was to determine the association between smoking status and total damage, as well as individual damage items, in SLE by ethnicity.

Methods: We analyzed data from a longitudinal Lupus Cohort. Damage was recorded using the Systemic Lupus Erythematosus International Collaborating Clinics/ American College of Rheumatology (SLICC/ACR) Damage Index. Poisson regression was used to model the total damage score against ever smoking. Cox regression was used to assess the relationship between time to damage items and ever smoking, stratified by ethnicity. Adjusted hazard ratios (HR) and 95% confidence intervals were reported. For each damage item, patients who had a damage diagnosis prior to or at the date of SLE diagnosis were excluded in the analysis.

Results: The study included 2629 patients. The prevalence of ever smokers was 35.8%. There was no significant difference in total damage score between eve smokers and never smokers after adjustment. Table 1 summarizes the Damage Index findings.

Ever smokers had more atherosclerotic cardiovascular (angina, coronary bypass, myocardial infarction and claudication) damage and skin damage compared to non-smokers. Caucasian SLE patients who ever smoked were more likely to have muscle atrophy. African- American patients who ever smoked were more likely to have any skin damage.

Conclusion: Smoking is a modifiable factor for organ damage in SLE. Our analysis proved the major effect was on cardiovascular damage (angina, coronary bypass, myocardial infarction and claudication). Surprisingly, these cardiovascular damage items have higher hazard ratios in Caucasian smokers. Smoking also increased some skin damage items. These skin damage items hazard ratios were higher in African-Americans.


Abstract- ACR 2019-RomyKallas-Table1

Table 1 – Adjusted Associations Between Damage Index Items and Smoking Status


Disclosure: R. Kallas, None; J. Li, None; M. Petri, Eli Lilly and Company, 5, Exagen, 2, 5.

To cite this abstract in AMA style:

Kallas R, Li J, Petri M. Association of African- American Ethnicity and Smoking Status and Total and Individual Damage Index in Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/association-of-african-american-ethnicity-and-smoking-status-and-total-and-individual-damage-index-in-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-african-american-ethnicity-and-smoking-status-and-total-and-individual-damage-index-in-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology